Date:
June 11, 2026
Content:
The U.S. Food and Drug Administration (FDA) has released an Establishment Inspection Report (EIR) regarding Blendhouse Portland LLC, a manufacturing facility located in Portland, Oregon. This release is part of the agency’s ongoing commitment to transparency within its FOIA Electronic Reading Room.
The inspection of the facility, which operates under FEI number 3013670080, resulted in the issuance of a Form 483. This document is utilized by the FDA to record observations made during an inspection that may indicate potential violations of federal regulatory requirements. The formal report for this manufacturer was issued on January 23, 2026.
As a registered manufacturer, Blendhouse Portland LLC is subject to federal oversight to ensure that its production processes and facilities meet safety and quality standards. The publication of this EIR provides public access to the agency’s findings during their site visit.
Source: FDA.gov
Link:
http://www.fda.gov/about-fda/fda-commissioner/blendhouse-portland-llc-portland-or-eir-issued-01232026
Keywords:
FDA, Blendhouse Portland LLC, EIR, Manufacturing, Portland Oregon, Form 483, Inspection Report